Generic drugs can be reliably supplied at big savings, study finds: University of Cambridge
2025 JUN 03 (NewsRx) -- By a
The study, by researchers from
The study, published in the journal NEJM Catalyst, was the first evaluation of the price effect of the CivicaScript model that focuses both on lowering the price of generic drugs and tackling the problem of drug shortages.
The researchers say that CivicaScript’s success proves that prioritizing patient access over investor profit in the generic pharmaceutical industry is not only possible, but also could be highly productive and cost efficient. The study focused on the period between September and
The US leads the world in prescription drug spending, reaching about
The researchers acknowledge the crucial role that patent protection plays in the marketplace development of important drugs, in order to pay for the risk-taking research and development of pharmaceutical and biotech companies, but say the market system now often fails to deliver on patent laws’ underlying assumptions.
“CivicaScript was launched to counter this market failure. The fact that many generic drugs remain prohibitively expensive for many patients defeats the purpose of the patent system, and the US debate over the sharp rise in insulin prices highlights this problem,” said co-author
Launched in 2020,
CivicaScript is based on the HCU model, a self-sustaining nonstock corporation with a social mission, formed by health care institutions to provide essential products at the lowest sustainable cost through a transparent and scalable business model. The CivicaScript model complements the direct-to-consumer model of the
“In contrast to the direct-to-consumer model, which bypasses the traditional insurance market, CivicaScript takes an inside-out approach,” said co-author
The branded version of abiraterone acetate, Zytiga, lost patent protection in 2018, but the drug still costs thousands of dollars per month for each patient. CivicaScript set the wholesale price of a bottle of 120 250-mg tablets, typically a month’s supply, at
The researchers collected and analysed pharmacy claims data from CivicaScript members, and compared payments per patient-month between CivicaScript and other manufacturers for the period September to
CivicaScript’s proof of concept showed that there are substantial opportunities for reducing generic drug costs for both patients and insurers, despite resistance from entrenched players in the drug supply chain. Its success with abiraterone acetate is evidence that reframing business models around sustainability and affordability, rather than profit maximisation, can generate meaningful cost savings.
The researchers say that CivicaScript faces obstacles from the current drug supply chain in getting its product to patients, citing a
(Our reports deliver fact-based news of research and discoveries from around the world.)


Wells Fargo freed from asset cap punishment imposed after fake account scandal
Findings on Insurance Detailed by Investigators at Center for Medicare & Medicaid Innovation (The First Decade of Aco Model Evaluations In the Medicare Program: a Systematic Review): Insurance
Advisor News
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
More Advisor NewsAnnuity News
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity NewsHealth/Employee Benefits News
- Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
- Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
- States get until July to cut Medicaid coverage over work requirement
- CRUSH Rule could crush health insurance agents, industry group says
- Despite rising healthcare costs, enrollment on Nevada insurance exchange is 'pretty steady'
More Health/Employee Benefits NewsLife Insurance News
- Military Briefs: November 19-25
- California’s new solvency rules: What should life insurance advisors watch?
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
More Life Insurance News